Literature DB >> 5937497

Fatal hyperkalemic paralysis associated with spironalactone. Observation on a patient with severe renal disease and refractory edema.

E Herman, J Rado.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5937497     DOI: 10.1001/archneur.1966.00470130078008

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  7 in total

1.  Diuretics. II. Other drugs.

Authors: 
Journal:  Br Med J       Date:  1969-07-26

2.  Spironolactone and diabetic ketoacidosis.

Authors:  A G Jariwalla; C R Jones; A Lever; R Hall
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

3.  Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy.

Authors:  Giampiero Giovacchini; Guillaume Nicolas; Heike Freidank; Thomas L Mindt; Flavio Forrer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-07       Impact factor: 9.236

4.  Haemodialysis in poisoning by sea-snake venom.

Authors:  V Sitprija; R Sribhibhadh; C Benyajati
Journal:  Br Med J       Date:  1971-07-24

5.  Hyperkalaemic paralysis due to spironolactone.

Authors:  E O Udezue; B P Harrold
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

6.  Hyperkalaemic paralysis following traumatic rupture of the urinary bladder.

Authors:  H Shinotoh; T Hattori; K Kitano; J Suzuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-05       Impact factor: 10.154

Review 7.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development.

Authors:  Peter Kolkhof; Lars Bärfacker
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.